Nebulization of Mesenchymal Stem Cells Secretome Attenuates Acute Respiratory Distress Syndrome Caused by SARS-CoV-2 Corona Virus: An Open-Label, Controlled Trial

Nebulization of Mesenchymal Stem Cells Secretome Attenuates Acute Respiratory Distress Syndrome Caused by SARS-CoV-2 Corona Virus: An Open-Label, Controlled Trial

Background: Previous investigations have indicated the potential of mesenchymal stem cell (MSC) transplantation in treating COVID-19. However, the limited lifespan of transplanted cells constrains this therapeutic approach. the immunomodulatory, anti-inflammatory, and regenerative properties of MSCs...

Full description

Saved in:
Bibliographic Details
Main Authors: Masoumeh Baghalishahi, Maysam Yousefi, Seyed Noureddin Nematollahi-Mahani, Mahsa Ziasistani, Fahimeh Pourjafari, Mona Saheli
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-05-01
Series:Advanced Biomedical Research
Subjects:
covid-19
hospitalization
intensive care units
mesenchymal stem cells
oximetry
secretome
Online Access:https://journals.lww.com/10.4103/abr.abr_477_23
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journals.lww.com/10.4103/abr.abr_477_23

Similar Items